Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (405)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
137
4.330
Why?
Vulvar Neoplasms
6
2024
58
2.670
Why?
Carcinoma, Squamous Cell
9
2024
326
2.130
Why?
Carcinoma in Situ
7
2022
73
1.870
Why?
Uterine Neoplasms
10
2023
60
1.870
Why?
Carcinoma, Endometrioid
6
2021
38
1.550
Why?
Adenocarcinoma
10
2024
396
1.510
Why?
Tumor Suppressor Protein p53
3
2024
212
1.430
Why?
PAX2 Transcription Factor
7
2015
22
1.380
Why?
Uterine Cervical Neoplasms
7
2024
275
1.150
Why?
Ovarian Neoplasms
10
2024
449
1.140
Why?
Endometrial Hyperplasia
4
2019
14
1.090
Why?
Cannabidiol
6
2024
41
1.050
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2024
59
1.040
Why?
Stromal Cells
2
2016
75
0.980
Why?
Female
66
2024
27053
0.890
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.860
Why?
Plant Extracts
6
2024
174
0.850
Why?
Myometrium
2
2013
13
0.820
Why?
Endometrium
6
2023
40
0.790
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.740
Why?
Precancerous Conditions
3
2019
83
0.720
Why?
Immunohistochemistry
16
2024
955
0.720
Why?
Cannabis
6
2024
146
0.720
Why?
Aged, 80 and over
20
2024
3233
0.700
Why?
Middle Aged
35
2024
12579
0.670
Why?
Humans
70
2024
50419
0.670
Why?
Cystadenocarcinoma, Serous
4
2013
71
0.660
Why?
Peripheral Nerves
2
2015
48
0.600
Why?
Mutation
9
2024
1275
0.570
Why?
Aged
29
2024
9738
0.570
Why?
Placenta
6
2021
134
0.550
Why?
Cervix Uteri
2
2017
42
0.540
Why?
Adult
31
2024
13561
0.540
Why?
Epithelial-Mesenchymal Transition
2
2016
51
0.540
Why?
Adenosarcoma
1
2016
3
0.520
Why?
Polyps
1
2016
20
0.510
Why?
Uterine Cervical Dysplasia
1
2016
48
0.500
Why?
Neoplasm Staging
9
2024
738
0.490
Why?
Lymphatic Metastasis
6
2019
221
0.480
Why?
Papillomavirus Infections
3
2024
165
0.480
Why?
Fallopian Tubes
2
2012
22
0.480
Why?
Tumor Microenvironment
4
2021
221
0.480
Why?
Fibroma
1
2015
39
0.480
Why?
Prognosis
11
2024
1974
0.440
Why?
Neoplasm Invasiveness
6
2019
269
0.430
Why?
Observer Variation
4
2024
138
0.420
Why?
Pelvic Neoplasms
1
2011
14
0.380
Why?
Uterus
3
2023
84
0.370
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
77
0.370
Why?
Mice, Inbred C57BL
7
2024
1796
0.350
Why?
Ejaculatory Ducts
1
2010
3
0.340
Why?
Seminal Vesicles
1
2010
13
0.340
Why?
Neoplasm Recurrence, Local
4
2015
622
0.340
Why?
Reproducibility of Results
5
2024
1181
0.330
Why?
Spectrum Analysis, Raman
2
2021
55
0.330
Why?
Prostate
1
2010
114
0.320
Why?
Mice
16
2024
5659
0.320
Why?
Bromcresol Purple
1
2009
3
0.320
Why?
Electrophoresis, Capillary
1
2009
10
0.320
Why?
Serum Albumin
1
2009
57
0.310
Why?
Human papillomavirus 16
2
2021
43
0.310
Why?
Methionine
2
2020
134
0.300
Why?
beta Catenin
2
2021
96
0.300
Why?
Disease Progression
4
2020
825
0.290
Why?
Predictive Value of Tests
5
2024
924
0.290
Why?
Liver
4
2024
1126
0.290
Why?
Diabetes Mellitus
2
2023
281
0.290
Why?
Genital Neoplasms, Female
2
2018
41
0.280
Why?
Papillomavirus Vaccines
2
2021
66
0.280
Why?
Anus Neoplasms
2
2018
24
0.280
Why?
Cell Proliferation
4
2021
980
0.270
Why?
Metaplasia
2
2019
15
0.270
Why?
Antigens, CD
2
2019
221
0.270
Why?
Diagnosis, Differential
8
2020
1029
0.270
Why?
Prostatic Neoplasms
1
2010
386
0.260
Why?
Colitis
2
2020
50
0.260
Why?
Polyethylene Glycols
2
2017
84
0.250
Why?
Melanoma
2
2020
278
0.250
Why?
Neoplasm Grading
5
2021
122
0.250
Why?
Animals
17
2024
13063
0.250
Why?
Hypertension
2
2021
545
0.240
Why?
Chi-Square Distribution
2
2016
275
0.240
Why?
Gold
2
2017
128
0.240
Why?
Proteomics
3
2017
313
0.240
Why?
Nanoparticles
2
2017
148
0.230
Why?
Young Adult
7
2024
4075
0.230
Why?
Aspartic Acid Endopeptidases
2
2015
16
0.230
Why?
Lab-On-A-Chip Devices
1
2024
9
0.230
Why?
Retrospective Studies
11
2020
6274
0.230
Why?
Racemases and Epimerases
2
2015
17
0.230
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
2
0.220
Why?
Carcinoma, Neuroendocrine
1
2024
22
0.220
Why?
Neuroendocrine Tumors
1
2024
23
0.220
Why?
DNA Mutational Analysis
3
2024
175
0.220
Why?
Head and Neck Neoplasms
2
2019
288
0.220
Why?
Kidney Neoplasms
2
2018
174
0.210
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
39
0.210
Why?
Homeodomain Proteins
1
2024
79
0.210
Why?
Lung Neoplasms
2
2019
597
0.210
Why?
Chlamydia muridarum
1
2024
40
0.210
Why?
Endometriosis
1
2023
14
0.210
Why?
Gynecology
2
2020
48
0.200
Why?
Chlamydia Infections
1
2024
75
0.200
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.200
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.200
Why?
Hepatocytes
2
2024
179
0.200
Why?
CD4-Positive T-Lymphocytes
1
2024
158
0.200
Why?
Fallopian Tube Neoplasms
2
2012
14
0.190
Why?
Immunotherapy
2
2021
234
0.190
Why?
Gestational Trophoblastic Disease
2
2012
2
0.190
Why?
Genotype
2
2021
525
0.190
Why?
CTLA-4 Antigen
1
2021
22
0.190
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.180
Why?
Estrogens
2
2023
225
0.180
Why?
Oncogene Fusion
1
2021
4
0.180
Why?
PTEN Phosphohydrolase
3
2020
53
0.180
Why?
Leiomyosarcoma
1
2021
20
0.180
Why?
Transcription Factors
3
2020
561
0.180
Why?
Diabetes, Gestational
1
2021
51
0.180
Why?
Cancer Vaccines
1
2021
80
0.180
Why?
Carcinosarcoma
2
2017
18
0.170
Why?
Infant, Small for Gestational Age
1
2020
32
0.170
Why?
Carcinoma, Papillary
1
2020
47
0.170
Why?
Neoplasms, Experimental
1
2020
111
0.170
Why?
Carcinoma, Transitional Cell
1
2020
51
0.170
Why?
Pregnancy in Diabetics
1
2020
25
0.170
Why?
Colonic Neoplasms
1
2021
156
0.170
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.160
Why?
Radiotherapy
1
2020
125
0.160
Why?
Carcinoma, Lewis Lung
1
2019
9
0.160
Why?
Pregnancy Complications, Neoplastic
1
2019
23
0.160
Why?
Placenta Diseases
1
2019
13
0.160
Why?
Carcinoma, Renal Cell
2
2018
101
0.160
Why?
Dermatology
1
2020
75
0.160
Why?
Premature Birth
1
2021
145
0.160
Why?
Skin Diseases
1
2020
126
0.160
Why?
Hepatic Veno-Occlusive Disease
1
2019
9
0.160
Why?
Odds Ratio
3
2015
550
0.160
Why?
Melanoma, Experimental
1
2019
40
0.160
Why?
T-Lymphocytes
1
2021
325
0.160
Why?
Hodgkin Disease
1
2019
45
0.160
Why?
DNA Polymerase II
1
2019
9
0.160
Why?
DNA Mismatch Repair
1
2019
16
0.160
Why?
Fetal Diseases
1
2019
57
0.160
Why?
Inflammation
2
2020
607
0.160
Why?
Pregnancy
7
2021
2444
0.160
Why?
Sarcoma
1
2020
65
0.160
Why?
Monocytes
1
2019
130
0.160
Why?
Urinary Bladder Neoplasms
1
2020
158
0.150
Why?
Metformin
1
2020
67
0.150
Why?
CD8-Positive T-Lymphocytes
1
2019
127
0.150
Why?
Methionine Adenosyltransferase
1
2018
19
0.150
Why?
Nuclear Proteins
1
2020
235
0.150
Why?
Logistic Models
3
2015
901
0.150
Why?
Disease Models, Animal
6
2020
1431
0.150
Why?
Radiation Tolerance
1
2019
84
0.150
Why?
Hypoglycemic Agents
1
2020
174
0.150
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.150
Why?
Rhabdomyosarcoma
1
2018
10
0.140
Why?
DNA Helicases
1
2020
147
0.140
Why?
Programmed Cell Death 1 Receptor
1
2018
37
0.140
Why?
Intestinal Mucosa
2
2020
214
0.140
Why?
Pathology, Molecular
1
2017
22
0.140
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
67
0.140
Why?
Biopsy
5
2020
588
0.140
Why?
Tumor Necrosis Factor-alpha
2
2019
386
0.140
Why?
Pregnancy Complications
1
2021
379
0.140
Why?
Osteosarcoma
1
2017
45
0.130
Why?
Neoplastic Cells, Circulating
1
2017
74
0.130
Why?
Gene Expression Profiling
2
2019
1020
0.130
Why?
Vimentin
1
2016
31
0.130
Why?
Time Factors
3
2021
2933
0.130
Why?
Papillomaviridae
1
2017
101
0.130
Why?
DNA-Binding Proteins
2
2016
410
0.130
Why?
Acetaminophen
1
2019
276
0.130
Why?
Oligonucleotide Array Sequence Analysis
1
2017
400
0.130
Why?
Cadherins
1
2016
61
0.130
Why?
Viral Load
1
2016
76
0.120
Why?
Male
11
2024
25866
0.120
Why?
Skin Neoplasms
1
2020
492
0.120
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.120
Why?
Neoplasms, Muscle Tissue
1
2015
11
0.120
Why?
Classification
1
2015
12
0.120
Why?
Colposcopy
1
2015
17
0.120
Why?
Malate Dehydrogenase
1
2014
9
0.120
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
17
0.120
Why?
Flow Cytometry
1
2017
472
0.120
Why?
Lipogenesis
1
2014
28
0.120
Why?
World Health Organization
1
2015
50
0.120
Why?
Mice, Inbred BALB C
3
2021
293
0.120
Why?
Cytosol
1
2014
80
0.110
Why?
Adolescent
4
2024
6453
0.110
Why?
Histones
1
2016
294
0.110
Why?
Neoplasm, Residual
1
2015
161
0.110
Why?
Mammary Neoplasms, Experimental
1
2015
121
0.110
Why?
Obesity
1
2022
1123
0.110
Why?
Multiple Myeloma
1
2009
2990
0.110
Why?
High-Throughput Nucleotide Sequencing
3
2021
162
0.110
Why?
Antineoplastic Agents
2
2021
1165
0.110
Why?
Gastrointestinal Tract
1
2014
103
0.110
Why?
Intestines
1
2014
152
0.110
Why?
Cell Line, Tumor
4
2020
1393
0.110
Why?
Oncogenes
1
2013
54
0.110
Why?
Patient Selection
1
2015
257
0.100
Why?
Membrane Proteins
1
2015
337
0.100
Why?
Clusterin
1
2012
6
0.100
Why?
Pancreatic Neoplasms
1
2015
204
0.100
Why?
Dose-Response Relationship, Drug
3
2024
1369
0.100
Why?
Risk Factors
3
2015
3712
0.100
Why?
Histocytochemistry
1
2012
47
0.100
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
22
0.100
Why?
Strongyloidiasis
1
2012
10
0.100
Why?
Follow-Up Studies
2
2016
2231
0.100
Why?
Treatment Outcome
3
2021
5265
0.100
Why?
Cytomegalovirus Infections
1
2012
37
0.090
Why?
Prednisone
1
2012
101
0.090
Why?
Vascular Endothelial Growth Factor A
1
2012
180
0.090
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
10
0.090
Why?
Teratoma
1
2011
22
0.090
Why?
Matrix Metalloproteinases
1
2011
46
0.090
Why?
Sensitivity and Specificity
3
2020
855
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Image Processing, Computer-Assisted
1
2012
245
0.090
Why?
Phenotype
3
2019
736
0.090
Why?
Tissue Array Analysis
3
2015
45
0.080
Why?
Glucocorticoids
1
2012
233
0.080
Why?
Tumor Cells, Cultured
2
2021
453
0.080
Why?
Epigenesis, Genetic
1
2012
371
0.080
Why?
Pregnancy Outcome
2
2021
205
0.080
Why?
Infant, Newborn
3
2021
2752
0.080
Why?
Pilot Projects
2
2023
694
0.080
Why?
Phosphatidylinositol 3-Kinases
2
2024
139
0.080
Why?
Telemedicine
1
2015
468
0.080
Why?
Necrosis
2
2024
173
0.070
Why?
Cell Differentiation
2
2024
640
0.070
Why?
Hysterectomy
2
2021
88
0.070
Why?
Cell Nucleus
2
2021
183
0.070
Why?
Societies, Medical
2
2019
189
0.070
Why?
Host-Pathogen Interactions
2
2021
134
0.070
Why?
Gene Expression Regulation
3
2023
948
0.070
Why?
Neoplasms
1
2017
1248
0.070
Why?
Consensus
2
2020
159
0.070
Why?
Ventricular Pressure
1
2006
16
0.070
Why?
Isoproterenol
1
2006
56
0.070
Why?
Terminology as Topic
2
2018
67
0.070
Why?
Kaplan-Meier Estimate
2
2018
462
0.070
Why?
Serum Response Factor
1
2006
40
0.070
Why?
Combined Modality Therapy
2
2020
640
0.060
Why?
Kidney
1
2010
690
0.060
Why?
Practice Guidelines as Topic
2
2019
473
0.060
Why?
Cytokines
2
2020
602
0.060
Why?
Neoplasm Metastasis
2
2018
230
0.060
Why?
Cells, Cultured
2
2021
1563
0.060
Why?
Proportional Hazards Models
2
2017
416
0.060
Why?
Chromatography, Liquid
2
2016
231
0.060
Why?
Bilirubin
1
2024
41
0.060
Why?
Tandem Mass Spectrometry
2
2016
238
0.060
Why?
Species Specificity
1
2024
182
0.060
Why?
Heart
1
2006
341
0.060
Why?
Steroids
1
2024
57
0.050
Why?
Th1 Cells
1
2024
52
0.050
Why?
Interleukin-10
1
2024
84
0.050
Why?
Phylogeny
1
2024
195
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
831
0.050
Why?
Government Agencies
1
2022
15
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
66
0.050
Why?
Hemorrhage
1
2024
195
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
8
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.050
Why?
Parturition
1
2021
49
0.050
Why?
Phthalazines
1
2021
20
0.050
Why?
Remission Induction
1
2021
208
0.050
Why?
Quinazolines
1
2021
33
0.040
Why?
Lymphocyte Activation
1
2021
169
0.040
Why?
Vulva
1
2020
17
0.040
Why?
Taurine
1
2020
18
0.040
Why?
Research Report
1
2020
16
0.040
Why?
Metabolic Networks and Pathways
1
2021
92
0.040
Why?
Herb-Drug Interactions
1
2020
32
0.040
Why?
Mucin-2
1
2020
8
0.040
Why?
Toxicity Tests
1
2020
54
0.040
Why?
Alkaline Phosphatase
1
2020
94
0.040
Why?
Risk
1
2021
325
0.040
Why?
Molecular Targeted Therapy
1
2021
122
0.040
Why?
Piperazines
1
2021
120
0.040
Why?
United States
3
2016
5005
0.040
Why?
Chemokines
1
2020
75
0.040
Why?
Birth Weight
1
2020
104
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
568
0.040
Why?
Preoperative Period
1
2020
46
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
34
0.040
Why?
Pyrimidines
1
2021
187
0.040
Why?
Colon
1
2020
95
0.040
Why?
Endothelium
1
2019
37
0.040
Why?
Mice, Transgenic
2
2014
537
0.040
Why?
Chest Pain
1
2019
55
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
31
0.040
Why?
Receptors, Progesterone
1
2020
64
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
61
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
191
0.040
Why?
Glutamine
1
2020
175
0.040
Why?
Dyspnea
1
2019
75
0.040
Why?
Estrogen Receptor alpha
1
2020
90
0.040
Why?
Liver Function Tests
1
2019
45
0.040
Why?
Fatal Outcome
1
2019
197
0.040
Why?
Mice, Inbred Strains
1
2019
159
0.040
Why?
Drug Synergism
1
2019
149
0.040
Why?
Gestational Age
1
2020
370
0.040
Why?
Imaging, Three-Dimensional
1
2019
151
0.040
Why?
Mice, Nude
1
2019
247
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
210
0.040
Why?
Nephrectomy
1
2018
78
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
35
0.040
Why?
Skin
1
2020
382
0.040
Why?
Lymph Node Excision
1
2019
131
0.040
Why?
Ultrasonography, Prenatal
1
2019
160
0.040
Why?
Cell Lineage
1
2018
83
0.040
Why?
Mixed Tumor, Mullerian
1
2017
3
0.040
Why?
DNA Copy Number Variations
1
2018
109
0.030
Why?
Anal Canal
1
2017
22
0.030
Why?
Macrophages
1
2019
365
0.030
Why?
Lymph Nodes
1
2019
256
0.030
Why?
Transcriptome
1
2019
314
0.030
Why?
Disease-Free Survival
1
2017
439
0.030
Why?
Dietary Supplements
1
2020
449
0.030
Why?
Child
2
2024
6931
0.030
Why?
Telomerase
1
2016
25
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
37
0.030
Why?
Vaccines, Subunit
1
2016
14
0.030
Why?
Ontario
1
2016
48
0.030
Why?
Diet
1
2020
564
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Signal Transduction
1
2023
1608
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
81
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
118
0.030
Why?
S100 Proteins
1
2015
33
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
62
0.030
Why?
Cell Count
1
2015
150
0.030
Why?
Cell Hypoxia
1
2015
82
0.030
Why?
Pressure
1
2015
104
0.030
Why?
Drug Evaluation, Preclinical
1
2015
144
0.030
Why?
Blood Vessels
1
2015
71
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
46
0.030
Why?
Genetic Predisposition to Disease
1
2018
507
0.030
Why?
Random Allocation
1
2015
284
0.030
Why?
Prospective Studies
1
2020
2378
0.030
Why?
Immunoenzyme Techniques
1
2014
140
0.030
Why?
Radiotherapy Dosage
1
2015
248
0.030
Why?
Apoptosis
1
2020
1092
0.030
Why?
Proteome
1
2016
161
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
231
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
179
0.030
Why?
Likelihood Functions
1
2014
55
0.030
Why?
Anti-Bacterial Agents
1
2019
751
0.030
Why?
Multivariate Analysis
1
2015
583
0.030
Why?
Vaccination
1
2016
275
0.030
Why?
Genes, erbB-1
1
2013
8
0.030
Why?
Lipid Metabolism
1
2014
174
0.030
Why?
Gene Frequency
1
2013
93
0.030
Why?
SEER Program
1
2013
94
0.030
Why?
Adiposity
1
2014
137
0.030
Why?
Mesentery
1
2012
32
0.030
Why?
Communication
1
2015
256
0.030
Why?
Insulin Resistance
1
2014
267
0.020
Why?
Diet, High-Fat
1
2014
214
0.020
Why?
Research Design
1
2015
348
0.020
Why?
Rural Health Services
1
2015
170
0.020
Why?
Neoplasms, Glandular and Epithelial
1
2012
41
0.020
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.020
Why?
Pregnancy Proteins
1
2012
5
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
6
0.020
Why?
Ovary
1
2012
114
0.020
Why?
Socioeconomic Factors
1
2015
591
0.020
Why?
Angiopoietin-2
1
2012
15
0.020
Why?
Angiopoietin-1
1
2012
16
0.020
Why?
Ivermectin
1
2012
9
0.020
Why?
Antiparasitic Agents
1
2012
10
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
30
0.020
Why?
Infant
1
2020
3648
0.020
Why?
Algorithms
1
2015
624
0.020
Why?
Hydatidiform Mole
1
2011
2
0.020
Why?
RNA, Messenger
1
2014
1085
0.020
Why?
Crohn Disease
1
2012
93
0.020
Why?
Interleukin-6
1
2012
261
0.020
Why?
Isoenzymes
1
2011
165
0.020
Why?
Promoter Regions, Genetic
1
2012
455
0.020
Why?
Gene Expression
1
2012
605
0.020
Why?
Risk Assessment
1
2015
1268
0.020
Why?
Radiography
1
2011
482
0.020
Why?
Cell Line
1
2012
997
0.020
Why?
Cohort Studies
1
2013
1451
0.020
Why?
DNA Methylation
1
2012
548
0.020
Why?
Rats
1
2014
3262
0.020
Why?
Blotting, Western
1
2006
575
0.020
Why?
Myocardium
1
2006
443
0.010
Why?
Age Factors
1
2006
1118
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description